Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy ...
Zacks Investment Research on MSN
CG Oncology stock gains 12% in three months: What's driving it?
Shares of CG Oncology CGON have risen 12% over the past three months against the industry’s 1.1% decline, primarily driven by ...
Among treatment-naive adults living with HIV, CD4 to CD8 ratios do not differ significantly between those on dolutegravir ...
Arbutus (ABUS) looks stronger after Moderna validates its LNP patents, with imdusiran showing durable viral control and a ...
The product targets patients on long-term NSAID therapy who face elevated risk of gastrointestinal complications.
Sam Neill's battle with rare blood cancer AITL highlighted its symptoms, diagnosis, CAR-T therapy advances, and the ...
UCSF is rolling out an aggressive new play in the fight against Alzheimer’s, launching a nationwide clinical trial that pairs ...
Fluoxetine, cognitive behavioral therapy, and combined therapy offer similar symptom reduction among youths with anxiety disorders.
Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer ...
The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva (nogapendekin alfa inbakicept) in ...
A Look at Heated Compression Foot Massagers and Where the EMSense Triple Therapy Device Sits in the Wider Conversation About At-Home Foot Comfort and Circulation Support An overview of the growing ...
FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results